This study is the first to employ a multimodal evaluation system to elucidate Gal-LNP-RSV's multi-dimensional protective mechanisms against NAFLD, reversing steatosis at the anatomical level, correcting lipid imbalance metabolically, and restoring redox homeostasis molecularly. This evidence concerns the gene GAL and metabolic dysfunction-associated steatotic liver disease.